Cited by

• Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.

  Zhang J, Huang Y, Pan J, Liu D, Zhou L, Xue W, Chen Q, Dong B, Xuan H. Zhang J, et al. J Cancer Res Clin Oncol. 2008 Nov;134(11):1211-8. doi: 10.1007/s00432-008-0399-x. Epub 2008 Apr 30. J Cancer Res Clin Oncol. 2008. PMID: 18446368
• Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack.

  Castro-Teles J, Sousa-Pinto B, Rebelo S, Pignatelli D. Castro-Teles J, et al. Endocr Connect. 2021 Oct 27;10(11):R293-R304. doi: 10.1530/EC-21-0294. Endocr Connect. 2021. PMID: 34596579 Free PMC article. Review.
• Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma.

  Losonczy G, Fazakas F, Pfliegler G, Komáromi I, Balázs E, Pénzes K, Berta A. Losonczy G, et al. BMC Med Genet. 2013 Jan 8;14:3. doi: 10.1186/1471-2350-14-3. BMC Med Genet. 2013. PMID: 23298237 Free PMC article.
• Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma.

  Lomte N, Kumar S, Sarathi V, Pandit R, Goroshi M, Jadhav S, Lila AR, Bandgar T, Shah NS. Lomte N, et al. Fam Cancer. 2018 Jul;17(3):441-449. doi: 10.1007/s10689-017-0058-y. Fam Cancer. 2018. PMID: 29124493
• A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?

  Azimi F, Aghajani A, Khakpour G, Chaibakhsh S. Azimi F, et al. Mol Genet Genomics. 2022 Nov;297(6):1615-1626. doi: 10.1007/s00438-022-01940-z. Epub 2022 Aug 25. Mol Genet Genomics. 2022. PMID: 36006455